GeoBlue earns URAC accreditation in health utilisation management

GeoBlue, which provides international medical insurance for US-based companies and individuals, has earned URAC accreditation for health utilisation management.

The Utilization Review Accreditation Commission (URAC) sets standards for clinical practice, consumer protections, performance measurement, operations infrastructure and risk management.

GeoBlue’s utilisation management services leverage its in-house clinical team to help members navigate foreign healthcare systems, and provide patient advocacy and education, especially for those with chronic conditions and diseases.

“Healthcare professionals know that utilisation management is an important component to ensure that patients receive the most appropriate care for their particular needs,” said URAC’s President and CEO, Shawn Griffin, MD. “URAC’s Health Utilization Management Accreditation is a demonstration of excellence in reviewer qualifications, efficient timelines, appeals and drug utilisation management.”

“We are extremely proud of this URAC accreditation, which validates our status as an outcomes-driven healthcare organisation committed to achieving high standards of care,” said Diego Fernández, GeoBlue President and CEO. “Our purpose is to simplify the international healthcare experience for our globally mobile members and utilisation management is an important tool to help us make good on that promise. These services help our members better manage their health, gain greater empowerment and improved outcomes, all while ensuring they receive quality, evidence-based care.”

In the latest ITIJ, GeoBlue’s Dr Damian Cornacchia and Lynn Pina talk about enhancing medical care for travellers across the globe.